Christoph Schramm, UKE Hamburg, Germany | ‘Primary sclerosing cholangitis: immune dysregulation in disease pathogenesis‘
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Andre Franke, Kiel University, Germany ‘Immunogenetic approaches to identify the culprit antigen in inflammatory bowel diseases’
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Bernd Schnabl, UC San Diego, USA “Nonbacterial Kingdoms of the Gut Microbiota and Alcohol-Associated Liver Disease“
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Mathias Heikenwälder, DKFZ Heidelberg, Germany | Title t.b.a.
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Tony Bruns, CRC1382, RWTH Aachen University | Title t.b.a.
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Jonel Trebicka, CRC1382, RWTH Aachen University | ‘Gut-liver-axis and decompensation of liver cirrhosis’
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Frank Tacke, CRC1382, Charité Berlin, Germany | ‘Macrophage heterogeneity in liver diseases’
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Maria Vehreschild, Frankfurt University, Germany | ‘Modulation of the Gut-Liver Axis through Fecal Microbiota Transfer’
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Rubén Francés, Alicante University Hospital, Spain | ‘Short-chain fatty acids and advanced chronic liver disease’
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Laure Bindels, Université catholique de Louvain, Brussels, Belgium | ‘Exploring the gut-liver axis in cancer cachexia’
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Max Nieuwdorp, Amsterdam UMC, The Netherlands | ‘Causality or association of gutmicrobiota and their metabolites in human NAFLD-NASH; potential for new diagnostic and therapeutic leads
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.
Mathias Hornef, CRC1382, RWTH Aachen University | Title t.b.a.
SuperC Templergraben 57, AachenPart of the International Symposium Functional Circuits and Therapeutic Targets. For further details see the programme on the dedicated website.